Pulmonx (LUNG) Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Payables data on file, last reported at $4.0 million in Q4 2025.

• On a quarterly basis, Payables fell 42.72% year-over-year to $4.0 million in Q4 2025; TTM through Dec 2025 was $4.0 million, a 42.72% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 42.72% from the prior year.
• Payables for Q4 2025 stood at $4.0 million, down from $6.5 million in the prior quarter.
• Over the last five years, Payables for LUNG reached as high as $18.9 million in Q4 2021 and fell as low as $1.8 million in Q4 2022.
• Historically, Payables has averaged $7.8 million across 5 years, with a median of $6.0 million in 2022.
• Across the five-year window, Payables slumped 90.23% in 2022 and surged 180.31% in 2024, its largest moves.
• Year by year, Payables stood at $18.9 million in 2021, then slumped by 90.23% to $1.8 million in 2022, then surged by 97.62% to $3.7 million in 2023, then soared by 91.76% to $7.0 million in 2024, then plunged by 42.72% to $4.0 million in 2025.
• Per Business Quant data, the three most recent Payables figures were $4.0 million in Q4 2025, $6.5 million in Q3 2025, and $6.7 million in Q2 2025.